Factors affecting faecal immunochemical test positive rates: Demographic, pathological, behavioural and environmental variables

Journal of Medical Screening

Volumn 22, Issue 4, 2015, Pages 187-193

  Symonds, Erin L ^a,c   Osborne, Joanne M ^a,c   Cole, Stephen R ^a,c   Bampton, Peter A ^b   Fraser, Robert J L ^a,b,c   Young, Graeme P ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

Colorectal cancer screening; Faecal immunochemical test; Haemoglobin stability; Occult blood; Temperature

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANALYSIS OF VARIANCE; CHEMISTRY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FECES; FEMALE; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; SOCIOECONOMICS; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84959327247     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141315584783     Document Type: Article

References (32)

1. Cole SR, Tucker GR, Osborne JM, et al. Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust 2013;198:327-330.
2. Ventura L, Mantellini P, Grazzini G, et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis 2014;46:82-86.
3. Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007;97:1601-1605.
4. Park DI, Ryu S, Kim YH, et al. Comparison of guaiacbased and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010;105:2017-2025.
5. Young GP, Symonds EL, Allison JE, et al. Advances in Fecal Occult Blood Tests: The FIT Revolution. Dig Dis Sci 2015;60:609-622.
6. Young GP, Cole SR. Which fecal occult blood test is best for colorectal cancer screening? Nat Clin Pract Gastroenterol Hepatol 2009;6:140-141.
7. The Australian bowel cancer screening pilot program and beyond. Final evaluation report: Australian Government Department of Health and Ageing, 2005.
8. AIHW. National Bowel Cancer Screening Program Monitoring report July 2011-June 2012: Australian Institute of Health and Welfare Canberra, 2013.
9. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-122.
10. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006;107:2152-2159.
11. Shin A, Choi KS, Jun JK, et al. Validity of fecal occult blood test in the national cancer screening program, Korea. PLoS One 2013;8:e79292.
12. Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Gastroenterol 2012;142:497-504.
13. van Roon AH, Hol L, van Vuuren AJ, et al. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. Am J Gastroenterol 2012;107:99-107.
14. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterol 2008;135:82-90.
15. Ciatto S, Martinelli F, Castiglione G, et al. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 2007;96:218-221.
16. Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer 2013;49:3049-3054.
17. Chubak J, Bogart A, Fuller S, Laing SS, Green BB. Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med 2013;57:671-678.
18. Zorzi M, Baracco S, Fedato C. Limited effect of summer warming on the sensitivity of colorectal cancer screening. Gut 2012;61:162; author reply.
19. Grazzini G, Zappa M, Ventura L, Rubeca T, Halloran SP. Authors' Reply. Gut 2011;60:1304.
20. Grazzini G, Ventura L, Zappa M, et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut 2010;59:1511-1515.
21. Cha JM, Lee JI, Joo KR, et al. Performance of the fecal immunochemical test is not decreased by high ambient temperature in the rapid return system. Dig Dis Sci 2012;57:2178-2183.
22. van Rossum LG, van Oijen MG. Different seasons with decreased performance of immunochemical faecal occult blood tests in colorectal cancer screening. Gut 2011;60:1303-1304; author reply 4.
23. Digby J, McDonald PJ, Strachan JA, Libby G, Steele RJ, Fraser CG. Deprivation and faecal haemoglobin: implications for bowel cancer screening. J Med Screen 2014;21:95-97.
24. Fraser CG, Rubeca T, Rapi S, Chen LS, Chen HH. Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening. Clin Chem Lab Med 2014;52:1211-1216.
25. McDonald PJ, Strachan JA, Digby J, Steele RJ, Fraser CG. Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer. Clin Chem Lab Med 2012;50:935-940.
26. Meteorology AGBo. Climate Data Online www. bom. gov. au/climate/data. 2013.
27. Mansouri D, McMillan DC, Grant Y, Crighton EM, Horgan PG. The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme. PLoS One 2013;8:e66063.
28. Young GP. Population-based screening for colorectal cancer: Australian research and implementation. J Gastroenterol Hepatol 2009;24(Suppl 3): S33-42.
29. Ward PR, Javanparast S, Matt MA, et al. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia. Aust N Z J Public Health 2011;35:61-65.
30. Digby J, Fraser CG, Carey FA, et al. Faecal haemoglobin concentration is related to severity of colorectal neoplasia. J Clin Pathol 2013;66:415-419.
31. Morikawa T, Kato J, Yamaji Y, et al. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol 2007;102:2259-2264.
32. Garcia M, Mila N, Binefa G, Borras JM, Espinas JA, Moreno V. False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010. J Med Screen 2012;19:77-82.